β-Thalassemia (β-thal) is an inherited blood disorder caused by reduced or absent synthesis of β-globin chains leading to imbalance of globin chain synthesis. β-Thalassemia (β-thal), refers to the complete absence of β-globin chain production on the affected allele. β-Thalassemia (β-thal) refers to alleles with some residual production of β-globin chain. We studied the correlation of genotype/phenotype of β-thal disease in Syrian patients. A cross-sectional study was carried out on 260 patients with β-thal. Genotyping was determined by a DNA sequencing technique. Routine investigations were performed to assess the complete blood count (CBC), serum ferritin, Hb A and Hb F levels. We found that the β/β genotype was the most common in our patients followed by β/β and β/β. Patients with β/β received transfusions at an earlier age and more frequently when compared to those with β/β and β/β genotypes. Moreover, patients with β/β had higher levels of Hb F and lower levels of Hb A compared to those with β/β and β/β genotypes. All patients with β-thal intermedia (β-TI) carry the β/β genotype, while all patients with β/β and β/β genotypes presented with transfusion-dependent β-thal major (β-TM).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/03630269.2019.1709207 | DOI Listing |
Zhong Nan Da Xue Xue Bao Yi Xue Ban
July 2024
Department of Nephrology, Third Xiangya Hospital, Central South University, Changsha 410013.
Objectives: Genetic factors play an important role in the pathogenesis of diabetic kidney disease (DKD). Studies have shown that gene polymorphism is associated with the pathogenesis of type 2 diabetes mellitus (T2DM), but its role in DKD remains unclear. This study aims to analyze the distribution of alleles and genotypes of gene in patients with T2DM, and investigate the association between genetic polymorphism and DKD susceptibility in T2DM patients, which may provide new ideas for the pathogenesis of DKD.
View Article and Find Full Text PDFJ Am Acad Dermatol
February 2025
Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Experimental, Diagnostic and Specialty Medicine Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Background: Baricitinib, an oral selective Janus kinase inhibitor, is approved to treat adults with severe alopecia areata (AA).
Objective: To report the week 152 efficacy results from the phase 3 trial BRAVE-AA2 down-titration substudy.
Methods: BRAVE-AA2 enrolled 546 adults with severe AA (Severity of Alopecia Tool [SALT] score ≥50).
J Eur Acad Dermatol Venereol
October 2024
Clifton Insight, Bristol, UK.
Comput Biol Chem
December 2024
Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology, (BHU), Varanasi, Uttar Pradesh 221005, India. Electronic address:
A medicinal pteridophyte known as Attukal Kizhangu L. has been used to cure patients for centuries by administering plant parts based on conventional and common practices. Regarding its biological functions, significant use and advancement have been made.
View Article and Find Full Text PDFIntroduction And Importance: Hamartomas are abnormal growths that consist of various types of mesenchymal tissues, including cartilage, fat, connective tissue, and smooth muscle. These tumors can occur in almost any organ system within the body. While head and neck hamartomas have been frequently documented, cases involving the lower limbs are relatively rare.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!